Pfizer Results Hurt by Pricing Challenges

Pfizer reported a fourth-quarter loss as the pharmaceutical company faced pricing challenges in the U.S. and tougher generic competition.

from WSJ.com: US Business https://on.wsj.com/2RqlLrB
via IFTTT